Carlotta Gurioli
Overview
Explore the profile of Carlotta Gurioli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Starace M, Gurioli C, Orioni G, Cedirian S, Brunetti T, Rapparini L, et al.
Ital J Dermatol Venerol
. 2025 Feb;
PMID: 39927810
Background: Atopic dermatitis (AD) stands as the prevailing chronic relapsing inflammatory dermatosis within the general population. Scalp involvement is a minor but frequent feature of AD, nevertheless it was relatively...
2.
Zengarini C, Mussi M, La Placa M, Pileri A, Virdi A, Chessa M, et al.
Sex Transm Infect
. 2025 Jan;
PMID: 39880595
Objectives: Scabies infestation, caused by the mite, has recently emerged as a public health concern in Western nations, with increased incidence worldwide. In Bologna, Italy, local health authorities report a...
3.
Starace M, Cedirian S, Quadrelli F, Pampaloni F, Brunetti T, Chessa M, et al.
Dermatol Pract Concept
. 2024 Dec;
14(4).
PMID: 39652913
Introduction: Dupilumab, a monoclonal antibody targeting IL-4 receptor subunit alpha, treats atopic dermatitis (AD) and may impact alopecia areata (AA). AA involves Th1-driven immune activity, and recent studies suggest a...
4.
Gargiulo L, Ibba L, Alfano A, Malagoli P, Amoruso F, Balato A, et al.
J Dermatolog Treat
. 2024 Oct;
35(1):2411855.
PMID: 39389612
Abrocitinib is a JAK-1 inhibitor approved for the treatment of moderate-to-severe atopic dermatitis (AD). We conducted a 16-week multicenter retrospective study to assess the short-term effectiveness and safety of abrocitinib...
5.
Pezzolo E, Narcisi A, Gargiulo L, Di Lernia V, Napolitano M, Patruno C, et al.
J Am Acad Dermatol
. 2024 Jul;
91(5):e147-e150.
PMID: 39047985
No abstract available.
6.
Starace M, Cedirian S, Gurioli C, Chessa M, Piraccini B, Neri I
Dermatol Pract Concept
. 2024 Feb;
14(1).
PMID: 38364419
No abstract available.
7.
Avallone G, Cavallo F, Tancredi A, Maronese C, Bertello M, Fraghi A, et al.
J Eur Acad Dermatol Venereol
. 2024 Jan;
38(9):1799-1808.
PMID: 38284131
Background: There is limited epidemiological evidence on outcomes associated with dupilumab exposure during pregnancy; monitoring pregnancy outcomes in large populations is required. Objective: To investigate the potential association between exposure...
8.
Avallone G, Mastorino L, Tavoletti G, Macagno N, Barei F, Schena D, et al.
J Am Acad Dermatol
. 2024 Jan;
90(5):1031-1034.
PMID: 38199282
No abstract available.
9.
Gurioli C, Misciali C, Robuffo S, Baraldi C, Boling L, Piraccini B
Dermatol Pract Concept
. 2023 Nov;
13(4).
PMID: 37992393
No abstract available.
10.
Neri I, Rapparini L, Paolo Salamone F, Leuzzi M, Gurioli C, Piraccini B
Dermatol Pract Concept
. 2023 Nov;
13(4).
PMID: 37992366
No abstract available.